Suppr超能文献

接受吸入性糖皮质激素/长效β2受体激动剂治疗的哮喘成年患者和无哮喘的成年患者血清骨膜蛋白的日间变化。

Day-time variation of serum periostin in asthmatic adults treated with ICS/LABA and adults without asthma.

作者信息

Caswell-Smith Rachel, Cripps Terrianne, Charles Thom, Hosking Alexander, Handigol Meghana, Holweg Cecile, Matthews John, Holliday Mark, Maillot Corentin, Fingleton James, Weatherall Mark, Beasley Richard, Braithwaite Irene

机构信息

Medical Research Institute of New Zealand, Private Bag 7902, Wellington, 6242 New Zealand.

Victoria University of Wellington, Wellington, New Zealand.

出版信息

Allergy Asthma Clin Immunol. 2017 Feb 8;13:8. doi: 10.1186/s13223-017-0182-0. eCollection 2017.

Abstract

BACKGROUND

We aimed to determine the effect of sampling time during the day on serum periostin levels in adult participants with and without asthma.

METHODS

Serum periostin was measured at 2-h intervals from 0800 to 1800 h in 16 adult participants with stable asthma prescribed inhaled corticosteroid and long-acting beta-agonist therapy, and in 16 otherwise healthy participants without asthma. Mixed linear models were used to compare time zero (08:00 h) with subsequent measurement time for serum periostin for both groups.

RESULTS

In both asthma and non-asthma, the mean (SD) serum periostin levels continuously reduced during the day from 53.5 (13.6) ng/mL at 0800 h to 50.9 (13.4) ng/mL at 1800 h (difference log periostin -0.05, P ≤ 0.001) and 50.5 (13.0) ng/mL at 0800 h to 46.2 (11.5) ng/mL at 1800 h (difference log periostin -0.08, P ≤ 0.001) respectively.

CONCLUSIONS

Periostin values are higher in the morning compared with the afternoon in asthmatic and non-asthmatic adults. The small magnitude of the variation in serum periostin levels suggests that the time of day in which the serum periostin measurements are made is unlikely to influence treatment decisions if a specific serum periostin level is used to predict treatment responsiveness. Australia New Zealand Trials Registry (ACTRN12614000072617).

摘要

背景

我们旨在确定一天中的采样时间对患有和未患哮喘的成年参与者血清骨膜蛋白水平的影响。

方法

对16名接受吸入性糖皮质激素和长效β-激动剂治疗的稳定期哮喘成年参与者以及16名无哮喘的健康成年参与者,于08:00至18:00每隔2小时测量一次血清骨膜蛋白。采用混合线性模型比较两组血清骨膜蛋白在时间零点(08:00)与后续测量时间的差异。

结果

在哮喘组和非哮喘组中,血清骨膜蛋白的平均(标准差)水平在一天中均持续下降,哮喘组从08:00时的53.5(13.6)ng/mL降至18:00时的50.9(13.4)ng/mL(骨膜蛋白对数差异为-0.05,P≤0.001),非哮喘组从08:00时的50.5(13.0)ng/mL降至18:00时的46.2(11.5)ng/mL(骨膜蛋白对数差异为-0.08,P≤0.001)。

结论

哮喘和非哮喘成年患者的骨膜蛋白值上午高于下午。血清骨膜蛋白水平变化幅度较小,这表明如果使用特定的血清骨膜蛋白水平来预测治疗反应性,那么进行血清骨膜蛋白测量的时间不太可能影响治疗决策。澳大利亚新西兰试验注册中心(ACTRN12614000072617)。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/176a/5299725/5dd6fedb60fb/13223_2017_182_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验